EUVIMEDEUVIMED entdecken
Crossref

FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice

Bo Zhou, Xiang Wang, Yao Wang, Danan Liu

Journal of Vascular Research · 2023

DOI: 10.1159/000531585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Research, 2023. Verfasst von Bo Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Atherosclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study attempted to observe the role of fibronectin type III domain-containing protein 5 (FNDC5) in atherosclerosis development and the underlying mechanism.

Methods

After being fed a high-fat diet (HFD), ApoE−/− mice were injected with saline, control adenovirus (Ad-vector), or FNDC5 overexpressing adenovirus (Ad-FNDC5). ApoE−/− mice fed with a chow diet were considered the control. After 12 weeks of treatment, the levels of serum high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), and irisin were detected by commercial kits.

Results

Compared with the control, the serum TG, TC, and LDL-C levels, aortic plaque area, and weight were significantly increased, while serum HDL-C and irisin levels were reduced in HFD mice. Treating with Ad-FNDC5 could alleviate these changes in HFD mice and cause the activation of PPARα/HO-1 signaling in aortic tissue. After co-treating with GW6471, a PPARα antagonist, the effects of Ad-FNDC5 on the weight, serum LDL-C, TC, TG, and HDL-C levels, and aortic plaque of HFD mice were partly blocked.

Conclusion

Elevated FNDC5 has a delaying effect on atherosclerotic plaque formation, which may be related to the upregulation of PPARα/HO-1 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticAtherosclerosisMiceAnimalsPPAR alphaCholesterolCholesterol, LDLFibronectinsMice, KnockoutMice, Knockout, ApoETriglyceridesDiet, High-FatApolipoproteins EMice, Inbred C57BL

Stichwörter der Autor:innen

ApoE−/−AtherosclerosisFNDC5HO-1PPARα

Substanzen

PPAR alphaCholesterolCholesterol, LDLFibronectinsTriglyceridesApolipoproteins EFNDC5 protein, mouse

Autor:innen und Institutionen

  • Institute of Medical Science, Guizhou Medical University, Guiyang, China.
  • The First People's Hospital of Bijie City, Bijie, China.
  • Department of Cardiology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.

Zitieren

APA

Zhou, B., Wang, X., Wang, Y., & Liu, D. (2023). FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice. Journal of Vascular Research. https://doi.org/10.1159/000531585

Vancouver

Zhou B, Wang X, Wang Y, Liu D. FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice. Journal of Vascular Research. 2023. doi:10.1159/000531585

BibTeX
@article{Zhou2023,
  author = {Zhou, Bo and Wang, Xiang and Wang, Yao and Liu, Danan},
  title = {FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice},
  journal = {Journal of Vascular Research},
  year = {2023},
  doi = {10.1159/000531585}
}
Kostenlos starten →